NeuBase Therapeutics Inc. is a biotechnology company specializing in the development of next-generation antisense therapies. With its unique peptide-nucleic acid platform, the company aims to revolutionize the treatment of genetic diseases by targeting specific genes with precision and efficacy. By merging the power of chemistry and biology, NeuBase is poised to transform the future of medicine.
